SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

por Glück, Vivian, Grobecker, Sonja, Tydykov, Leonid, Salzberger, Bernd, Glück, Thomas, Weidlich, Tanja, Bertok, Manuela, Gottwald, Christine, Wenzel, Jürgen J., Gessner, André, Schmidt, Barbara, Peterhoff, David
Publicado 2021

Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel

por Glück, Vivian, Grobecker, Sonja, Köstler, Josef, Tydykov, Leonid, Bertok, Manuela, Weidlich, Tanja, Gottwald, Christine, Salzberger, Bernd, Wagner, Ralf, Zeman, Florian, Koller, Michael, Gessner, André, Schmidt, Barbara, Glück, Thomas, Peterhoff, David
Publicado 2021

Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects

por Glück, Vivian, Tydykov, Leonid, Mader, Anna-Lena, Warda, Anne-Sophie, Bertok, Manuela, Weidlich, Tanja, Gottwald, Christine, Köstler, Josef, Salzberger, Bernd, Wagner, Ralf, Koller, Michael, Gessner, André, Schmidt, Barbara, Glück, Thomas, Peterhoff, David
Publicado 2022

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals

por Mader, Anna-Lena, Tydykov, Leonid, Glück, Vivian, Bertok, Manuela, Weidlich, Tanja, Gottwald, Christine, Stefl, Alexa, Vogel, Matthias, Plentz, Annelie, Köstler, Josef, Salzberger, Bernd, Wenzel, Jürgen J., Niller, Hans Helmut, Jantsch, Jonathan, Wagner, Ralf, Schmidt, Barbara, Glück, Thomas, Gessner, André, Peterhoff, David
Publicado 2022